The nasopharyngeal and respiratory mucosa represents a primary barrier to infection by inhaled organisms. However, many pathogens have adapted and can disseminate beyond the oral and respiratory mucosa to cause systemic disease. Such pathogens include Mycobacterium tuberculosis, Staphylococcus aureus, Streptococcus pneumonia, and Bacillus anthracis. Together these pathogens account for millions of deaths worldwide every year, and in particular, M. tuberculosis continues to be a devastating global pathogen, alone causing two million deaths annually and latently infecting a third of the world?s population. Lining the respiratory mucosa are specialized epithelial cells that function to transcytose mucosal antigens from the apical, mucosal lumen to the basolateral space. These cells, known as microfold or M-cells, overlie mucosal associated lymphatic tissue where macrophages and dendritic cells await to ingest and present antigens to B-cells and T- cells. We hypothesized that M. tuberculosis has evolved to penetrate the mucosa via M-cells, and our preliminary data indicate that M. tuberculosis indeed utilizes M-cells to initiate disease. Blocking M-cell development or secretion of an M. tuberculosis virulence factor prevents lymph node dissemination and mortality from M. tuberculosis infection in mice. We will apply genetic, biochemical, immunologic and animal approaches to determine the functional role of M-cells in mucosal and systemic immunity against respiratory pathogens. Thus, in the proposed research we will (1) Characterize the transcytosis machinery leveraged by bacteria to cross airway M-cells, (2) Assess the role of airway M-cells in inducing innate and adaptive immunity in mice and (3) Determine the role of airway M-cells in the immune response using primary human tissues. The proposed work is expected to identify how M-cells bind and transcytose M. tuberculosis and similar bacteria, and the consequences of M-cell mediated transcytosis to innate and adaptive immune responses.

Public Health Relevance

The role of microfold cells residing in the nasopharynx and respiratory tree in host defense and immune activation is poorly understood. We propose to study airway microfold cells as a portal of mucosal invasion by respiratory pathogens such as Mycobacterium tuberculosis, Staphylococcus aureus, and Streptoccocus pneumonia. We also propose to study how airway M-cells facilitate the development of innate and adaptive immune responses using cell culture, mouse and primary human models. This approach is novel because it represents the first broad characterization of the role of airway M-cells to host defense against respiratory pathogens.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI125939-04
Application #
9724341
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Rothermel, Annette L
Project Start
2016-07-21
Project End
2021-06-30
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
4
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390